Expression and Clinical Value of Survivin in Bladder Transitional Cell Carcinoma

孙友文,宣强,肖俊,周林玉,诸禹平
DOI: https://doi.org/10.3969/j.issn.1001-5930.2012.04.009
2012-01-01
Abstract:Objective To study the expression of Survivin in bladder transitional cell carcinoma(BTCC) and the relationship between its expression and the clinicopathological characteristics of BTCCs.Methods 68 cases of paraffin-embeded specimens of BTCC was taken as the experimental group and ten cases of non-tumor patients with normal bladder mucosa as a control group.Using immunohistochemical SP method to detect the expression of Survivin in all specimens,and the results were statistically analyzed.Results The positive rate of Survivin were 72.1% in the BTCC group and 0% in the normal group,respectively(P0.05).The positive rate of Survivin in pathological grade Ⅰ,Ⅱ and Ⅲ were respectively 45.8%,83.3% and 92.9%.There was statistically significant difference between gradeⅠand gradeⅡ,gradeⅢ(P0.05).That of Survivin in superficial,invasive;primary,recurrence;lymph node postive,negetive were 57.9%,90.0%;64.7%,94.1%;57.5%,92.9%;respectively(P0.05).Conclusion The abnormal high expression of Survivin may play an important role in occurrence and progress of BTCC.Detection of Survivin in BTCC is helpful in evaluating the occurrence,progress,metastasis,relapase of BTCC and the prognosis of the patients.Survivin also can provide a new appropriate target for gene therapy to BTCC.
What problem does this paper attempt to address?